The largest database of trusted experimental protocols

7 protocols using mog35 55

1

Intracellular Cytokine Staining of T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For intracellular cytokine staining (ICS) assays, T cells isolated from spleen of mice or from in vitro cultures were stimulated for 1.5 h with 100 mg/ml MOG(35-55) or PMA (50 ng/ml, Thermo Fisher Scientific, USA) and ionomycin (500 ng/ml, Thermo Fisher Scientific), before Brefeldin A (10 μg/ml, eBioscience, USA) was added to the culture for 3.5 h more. As previously described [32 (link)], for surface staining, cells were harvested, washed, and stained for 30 min on ice with mixtures of fluorescently conjugated mAbs or isotype-matched controls. For ICS, cells were stained for surface molecules, fixed 20 min in IC Fixation buffer (Thermo Fisher Scientific), and incubated for 1 h in permeabilization buffer (Thermo Fisher Scientific) with appropriate mAbs of mice. Antibodies used in this study are listed in Supplementary Table 1. Cell phenotype was analyzed by flow cytometry on a flow cytometer (BD LSR II) (BD Biosciences, USA) or Attune NxT (Thermo Fisher Scientific). Data were acquired as the fraction of labeled cells within a live-cell gate and analyzed using FlowJo software (Tree Star). All gates were set on the basis of isotype-matched control antibodies.
+ Open protocol
+ Expand
2

Intracellular Cytokine Staining of T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For intracellular cytokine staining assays, T cells isolated from spleen or nervous system of mice, or from in vitro cultures were stimulated for 1.5 h with 100 mg/mL MOG(35-55) or PMA (50 ng/mL, Thermo Fisher Scientific, USA) and ionomycin (500 ng/mL, Thermo Fisher Scientific), before Brefeldin A (10 μg/mL, eBioscience, USA) was added to the culture for 3.5 h more. As previously described 37 (link), for surface staining, cells were harvested, washed, and stained for 30 min on ice with mixtures of fluorescently conjugated mAbs or isotype-matched controls. For intracellular cytokine staining (ICS), cells were stained for surface molecules, fixed 20 min in IC Fixation buffer (Thermo Fisher Scientific), and incubated for 1 h in permeabilization buffer (Thermo Fisher Scientific) with appropriate mAbs of mice. Antibodies used in this study are listed in Table S1. Cell phenotype was analyzed by flow cytometry on a flow cytometer (BD LSR II) (BD Biosciences, USA) or Attune NxT (Thermo Fisher Scientific). Data were acquired as the fraction of labeled cells within a live-cell gate and analyzed using FlowJo software (Tree Star). All gates were set on the basis of isotype-matched control antibodies.
+ Open protocol
+ Expand
3

Passive EAE Induction via Adoptive Transfer

Check if the same lab product or an alternative is used in the 5 most similar protocols
WT female 8- to 12-wk-old donor mice were immunized as described for active EAE but did not receive PTX. At DPI10, spleen and dLNs (inguinal, axillary, and brachial) were collected and passed through a 70-µm filter (Falcon) to obtain a single-cell suspension. Cells were incubated with 1× RBC lysis buffer (BioLegend) for 5 min at 4°C. After centrifugation (500 ×g for 5 min at 4°C), cells were cultured in complete T cell media (5 × 106 cells/ml), DMEM (Corning) supplemented with 50 µg/ml MOG35–55, 25 ng/ml IL-12, and 10 ng/ml IFN-γ (Thermo Fisher Scientific). After 72 h, CD4+ T cells were collected using the Dynabeads Untouched Mouse CD4 Cells Kit (Thermo Fisher Scientific) and injected into recipient mice (106 cells/mouse i.p.). PTX was injected (200 ng/mouse i.p.) at days 0, 2, and 3 after CD4+ cell transfer. Clinical scoring and disease severity were assessed as above.
+ Open protocol
+ Expand
4

Adoptive Transfer Model of EAE

Check if the same lab product or an alternative is used in the 5 most similar protocols
Donor C57BL/6 mice were actively immunized with 100 μg MOG35–55 peptide emulsified in CFA (Difco). At day 9 after immunization, lymphocytes from the spleen, axillary, inguinal, and cervical lymph nodes were collected and cultured in vitro for 72–84 hr in complete T cell media (RPMI1640, 10% fetal bovine serum (GIBCO), 100 U/ml penicillin, 100 μg/ml streptomycin, 1X Glutamax (GIBCO), 1X MEM non-essential amino acid (GIBCO); 1mM sodium pyruvate (Sigma), 10mM HEPES (Lonza), and 50 μM β-mercaptoethanol). For T cell skewing, MOG35–55 (20 μg/ml), rmIL-6 (20 ng/ml, Peprotech), rmIL-12p70 (3 ng/ml, Peprotech), rmIL-23 (20 ng/ml, R&D), and human TGFb (4 ng/ml, Peprotech) were added to the media. 40 million cells from cultured lymphocytes were transferred intraperitoneally to C57BL/6 or BAFF-Tg recipient mice. At day 2 post-transfer, recipients also received 200ng of pertussis toxin.
+ Open protocol
+ Expand
5

Experimental Autoimmune Encephalomyelitis Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
For active EAE, mice were immunized subcutaneously (s.c.) on the back with 200 μg of MOG35-55 (MEVGWYRSPFSRVVHLYRNGK) emulsified in CFA (Difco Lab, Detroit, MI) containing 4 mg/ml Mycobacterium tuberculosis H37Ra (Difco). Two hundred ng of pertussis toxin (List Biological Lab, Epsom, England) was given i.p. on days 0 and 2 post immunization (p.i.). For passive EAE, GFAP-shIFN-γR or GFAP-shVec lentivirus injected mice were transferred with 3.0×107 polarized MOG35-55-specific Th1 or Th17 cells/mouse 4 hours after sublethal irradiation (550 Rad). To prepare MOG-specific polarized T cell populations, draining lymph nodes and spleen cells were prepared from mice immunized as described above at day 9 p.i. Cells were cultured for 4 days with MOG35-55 at a concentration of 25 μg/ml under Th1- (20 ng/ml rmIL-12 [PeproTech], 2 μg/ml anti-IL23p19 [eBioscience]) or Th17- (20 ng/ml rmIL-23 [PeproTech]) polarizing conditions (28 (link)). Mice were scored daily for appearance of clinical signs of EAE on a scale from 0 to 5 as described previously (29 (link)): 0, no clinical signs; 1, fully limp tail; 2, paralysis of one hind limb; 3, paralysis of both hind limbs; 4, paralysis of trunk; 5, moribund or death.
+ Open protocol
+ Expand
6

T-cell-transfer Experimental Autoimmune Encephalomyelitis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Six-week-old C57BL/6 female mice were purchased from Orient Bio (Gyeonggi, Korea). For T-cell-transfer EAE, mice were immunized with 300 μg myelin oligodendrocyte glycoprotein peptide (MOG35–55) peptide emulsified in complete freund’s adjuvant (CFA) with heat-inactivated Mycobacterium tuberculosis. Seven days after immunization, cells from draining lymph nodes were isolated and cultured with 20 μg/mL MOG35–55 and IL-23 (20 ng/mL) (PeproTech, Rocky Hill, NJ, USA). On day five post in vitro stimulation, cells were harvested and enriched with CD4+ T cells by using magnetic beads. The enriched CD4+ T cells (2 × 106 cells/mouse) were transferred into mice followed by immunization with MOG35–55 in CFA (s.c.) and subsequent pertussis toxin (PT) (i.p.) injection, and the clinical severity for EAE pathology was monitored daily as previously mentioned [20 (link)].
+ Open protocol
+ Expand
7

Adoptive Transfer of Autoimmune Encephalomyelitis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Donor mice (Cre littermates of Pdgfrb-CreERT2-MHCII mice) were immunized with 50 µg MOG35–55 peptide (generated by Rudolf Volkmer, Charite Berlin, Germany) emulsified in complete Freund’s adjuvant (Difco by BD, Sparks, MD, USA; 263810) including Mycobacterium tuberculosis (Difco by BD, Sparks, MD, USA; 231141) by s.c. injection. After 10 days immune cells from lymph nodes and spleen were isolated and in vitro re-stimulated for 72 h in the presence of 20 mg/mL MOG35–55 and 20 ng/mL IL-12 (Peprotech, Hamburg, Germany; 210-12). Cells (5 × 106) were injected i.p. into tamoxifen-treated recipient mice (Cre mice = MHC II WT, Cre+ mice = MHC II KO).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!